Hemispherian
Zeno is the Chief Executive Officer of Hemispherian. He has a master’s degree in computer science from the University of Oslo. He has extensive industry experience as an engineering manager and software engineer in the medical and defence sector. Zeno and Adam previously worked together to develop platform technologies for processing genome sequencing data.
Hemispherian
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Its mission is to development a new drug to treat Glioblastoma Multiforme.